Veterinary Medicines

DILPHES BG suspension for injection for cattle, sheep and goats

Authorised
  • Mannheimia haemolytica, serotype A2, strain CECT 924, Inactivated
  • Mannheimia haemolytica, serotype A1, strain ATCC 33365, Inactivated
  • Pasteurella multocida, serotype 6B, strain CECT 962, Inactivated
  • Pasteurella multocida, serogroup A, strain NCTC 12177, Inactivated
Download as PDF

Product identification

Medicine name:
DILPHES BG инжекционна суспензия за говеда, овце и кози
DILPHES BG suspension for injection for cattle, sheep and goats
Active substance:
  • Mannheimia haemolytica, serotype A2, strain CECT 924, Inactivated
  • Mannheimia haemolytica, serotype A1, strain ATCC 33365, Inactivated
  • Pasteurella multocida, serotype 6B, strain CECT 962, Inactivated
  • Pasteurella multocida, serogroup A, strain NCTC 12177, Inactivated
Target species:
  • Cattle
  • Sheep
  • Goat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Mannheimia haemolytica, serotype A2, strain CECT 924, Inactivated
    41.08
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Mannheimia haemolytica, serotype A1, strain ATCC 33365, Inactivated
    41.08
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Pasteurella multocida, serotype 6B, strain CECT 962, Inactivated
    100000.00
    50% Protective Dose
    /
    1.00
    Dose
  • Pasteurella multocida, serogroup A, strain NCTC 12177, Inactivated
    100000.00
    50% Protective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB04
  • QI03AB
  • QI04AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Asklep-Pharma OOD
Marketing authorisation date:
Manufacturing sites for batch release:
  • CZ Vaccines S.A.U.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2647
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 30/12/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 3/06/2022
Download